News Conference News TCT 2025 STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus Michael O'Riordan October 28, 2025
News Conference News TCT 2024 DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF Caitlin E. Cox October 28, 2024
News Conference News TCT 2021 FAVOR III China Adds Strength to Value of QFR-Guided PCI L.A. McKeown November 04, 2021
News Conference News TCT 2021 FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD Michael O'Riordan November 04, 2021
News Conference News TCT 2021 OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions L.A. McKeown October 25, 2021
News Conference News TCT 2020 Stent Polymer Face-off Calls Bioresorbable Coatings Into Question Shelley Wood October 17, 2020
News Conference News TCT 2019 IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI Caitlin E. Cox October 08, 2019
News Conference News TCT 2017 ORBITA: PCI Offers No Symptom Improvement Over Sham Procedure Michael O'Riordan November 02, 2017
News Conference News TCT 2017 No Advantage With Hybrid Revascularization for Multivessel Disease: HREVS Michael O'Riordan October 30, 2017
News Industry News TCT 2016 Hybrid Sirolimus-Eluting Stents with Biodegradable Polymer Did Not Improve Angiographic Outcomes Compared to Everolimus-Eluting Stents with Durable Polymer in Treatment of Chronic Total Occlusions November 02, 2016
News Industry News TCT 2016 Study Finds No Long-Term Clinical Benefit to Routine Follow-Up Coronary Angiography After PCI November 01, 2016
News Conference News TCT 2016 EXCEL and NOBLE: Opposing Results Pose Quandary for PCI/CABG Choice in Left Main Disease Michael O'Riordan October 31, 2016
News Conference News TCT 2016 ‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent Michael O'Riordan October 30, 2016
News Conference News TCT 2015 ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES Yael L. Maxwell October 12, 2015
Presentation TCT 2014 TCT 611: Multimodality Assessment 12 Months After Implantation of a Bioresorbable Scaffold for the Treatment of Culprit Lesions in Myocardial Infarction Presenter: Dariusz Dudek, Pieter C. Smits, Vincent On-Hing Kwok, Ulrich Hink September 16, 2014
News Conference News TCT 2014 ABSORB II: Similar Clinical Outcomes, Less Angina with Bioresorbable Scaffold vs. EES Yael L. Maxwell September 14, 2014
Presentation TCT 2013 Introduction of a New Definition of" Clinically Relevant" Myocardial Infarction: SCAI Consensus Document Presenter: Issam Moussa October 28, 2013
Presentation TCT 2012 EXAMINATION 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Bare Metal Stents in Patients with ST-Segment Elevation Myocardial Infarction Presenter: Manel Sabate October 25, 2012
Presentation TCT 2012 Long-term Safety and Effectiveness of Drug Eluting Stents Compared to Bare Metal Stents in Non ST Elevation Myocardial Infarction: Findings from the Guthrie Health Off-Label... Presenter: Sudhakar Sattur, Pam Orshaw, Judy Boura, Kishore Harjai January 03, 2012